$34.00
0.29[0.86%]
Last update: 6:00PM Get Real Time Here
Tarsus Pharmaceuticals
(NASDAQ:TARS)Latest News for Tarsus Pharmaceuticals Stock (NASDAQ:TARS)
Tarsus Pharmaceuticals Stock (NASDAQ: TARS)
Categories: All
Tuesday, April 23, 2024
Friday, March 01, 2024
Thursday, February 29, 2024
- Tarsus Pharmaceuticals Reveals Proposed $100M Public OfferingBenzinga Newsdesk - Feb 29, 2024, 4:47PM
- A Glimpse Into The Expert Outlook On Tarsus Pharmaceuticals Through 4 AnalystsBenzinga Insights - Feb 29, 2024, 7:00AM
- Goldman Sachs Maintains Neutral on Tarsus Pharmaceuticals, Raises Price Target to $30Benzinga Newsdesk - Feb 29, 2024, 6:08AM
Wednesday, February 28, 2024
- HC Wainwright & Co. Maintains Buy on Tarsus Pharmaceuticals, Raises Price Target to $57Benzinga Newsdesk - Feb 28, 2024, 2:04PM
- Barclays Maintains Overweight on Tarsus Pharmaceuticals, Raises Price Target to $50Benzinga Newsdesk - Feb 28, 2024, 11:15AM
- ICU Medical To Rally Around 28%? Here Are 10 Top Analyst Forecasts For WednesdayAvi Kapoor - Feb 28, 2024, 8:07AM
- Oppenheimer Reiterates Outperform on Tarsus Pharmaceuticals, Raises Price Target to $59Benzinga Newsdesk - Feb 28, 2024, 7:48AM
Tuesday, February 27, 2024
- Tarsus Pharmaceuticals shares are trading higher after the company reported better-than-expected Q4 financial results.Benzinga Newsdesk - Feb 27, 2024, 12:35PM
- Tarsus Pharmaceuticals Q4 EPS $(1.31) Beats $(1.36) Estimate, Sales $13.08M Beat $5.66M EstimateBenzinga Newsdesk - Feb 27, 2024, 12:27PM
- Earnings Scheduled For February 27, 2024Benzinga Insights - Feb 27, 2024, 5:01AM
Monday, February 26, 2024
Thursday, February 22, 2024
Monday, January 29, 2024
Monday, November 20, 2023
Friday, November 10, 2023
- Why Wynn Resorts Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day SessionLisa Levin - Nov 10, 2023, 1:34PM
- Tarsus Pharmaceuticals shares are trading higher following Q3 results.Benzinga Newsdesk - Nov 10, 2023, 12:11PM
- HC Wainwright & Co. Maintains Buy Rating for Tarsus Pharmaceuticals: Here's What You Need To KnowBenzinga Insights - Nov 10, 2023, 12:00PM
- Big Stocks Moving Higher On Friday: Synaptics Reports Q1 Beat; Joins Lyft, Hologic, Blink ChargingLisa Levin - Nov 10, 2023, 11:51AM
- HC Wainwright & Co. Maintains Buy on Tarsus Pharmaceuticals, Raises Price Target to $50Benzinga Newsdesk - Nov 10, 2023, 7:44AM
Thursday, November 09, 2023
Wednesday, November 08, 2023
Monday, September 11, 2023
Monday, August 14, 2023
Friday, August 11, 2023
Thursday, August 10, 2023
Wednesday, August 02, 2023
Tuesday, August 01, 2023
Monday, July 31, 2023
Wednesday, July 26, 2023
Tuesday, July 25, 2023
- Tarsus Pharma Shares Under Pressure: Analyst Says Concerns Over Adverse Event Profile OverblownVandana Singh - Jul 25, 2023, 3:39PM
- 12 Health Care Stocks Moving In Tuesday's Intraday SessionBenzinga Insights - Jul 25, 2023, 1:31PM
- Why Alaska Air Group Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionLisa Levin - Jul 25, 2023, 1:11PM
- The FDA Has Approved Tarsus Pharmaceuticals' Xdemvy (Lotilaner Ophthalmic Solution, Formerly TP-03) 0.25% For Demodex Blepharitis; Xdemvy Expected To Be Available By Prescription By The End Of August 2023Benzinga Newsdesk - Jul 25, 2023, 7:04AM